Rapha Capital Management, based in Florida, leads Seed to Series B rounds in life sciences and healthtech, writing checks from $250,000 to $30 million, and backs firms like Poseida Therapeutics.
1 person on the investing team, 1 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Rapha Capital Management reports entry at seed, series a, series b.
Rapha Capital Management reports checks of $250K to $30M.
Yes. Rapha Capital Management says it can lead.
Kevin Slawin, MD (Founder & Managing Partner).
No recent activity since September 2026.
Work at Rapha Capital Management? Claim or correct this profile.